MS
PACB icon

Maven Securities’s Pacific Biosciences PACB Stock Holding History

Maven Securities’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-250,000
Closed -$2.9M – 1001
2023
Q1 		$2.9M Buy
+250,000
New +$2.49M 0.06% 220
2021
Q1 		– Sell
-57,213
Closed -$1.51M – 1262
2020
Q4 		$1.51M Buy
+57,213
New +$972K 0.15% 175
2019
Q2 		– Sell
-183,854
Closed -$1.33M – 96
2019
Q1 		$1.33M Buy
183,854
+120,254
+189% +$870K 1.18% 25
2018
Q4 		$464K Buy
+63,600
New +$403K 0.28% 38

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return